GPS Wealth Strategies Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$235K Sell
447
-53
-11% -$27.8K 0.03% 302
2025
Q1
$317K Sell
500
-71
-12% -$45K 0.04% 234
2024
Q4
$407K Sell
571
-60
-10% -$42.7K 0.05% 198
2024
Q3
$664K Buy
631
+37
+6% +$38.9K 0.09% 150
2024
Q2
$625K Buy
594
+82
+16% +$86.2K 0.09% 134
2024
Q1
$492K Sell
512
-1
-0.2% -$962 0.08% 155
2023
Q4
$451K Buy
513
+70
+16% +$61.5K 0.08% 159
2023
Q3
$365K Buy
443
+35
+9% +$28.8K 0.07% 174
2023
Q2
$293K Buy
408
+153
+60% +$110K 0.05% 201
2023
Q1
$210K Buy
+255
New +$210K 0.04% 234
2022
Q4
Sell
-229
Closed -$158K 869
2022
Q3
$158K Sell
229
-2
-0.9% -$1.38K 0.04% 233
2022
Q2
$137K Sell
231
-11
-5% -$6.52K 0.04% 261
2022
Q1
$169K Buy
242
+19
+9% +$13.3K 0.04% 232
2021
Q4
$141K Buy
223
+27
+14% +$17.1K 0.03% 247
2021
Q3
$119K Buy
196
+64
+48% +$38.9K 0.03% 257
2021
Q2
$74K Hold
132
0.02% 347
2021
Q1
$62K Buy
+132
New +$62K 0.02% 346